View in EDS HTML Full Text PDF Full Text

Acquired MTAP Loss Following Entrectinib Resistance in ROS1‐Rearranged NSCLC With CD74 Exon 3–ROS1 Exon 34 Fusion.

Saved in:
Bibliographic Details
Title: Acquired MTAP Loss Following Entrectinib Resistance in ROS1‐Rearranged NSCLC With CD74 Exon 3–ROS1 Exon 34 Fusion.
Authors: Haraguchi Hashiguchi, Mizuha1 (AUTHOR) mizuha.haraguchi@gmail.com, Tanino, Maika1 (AUTHOR), Yoneda, Suzuyuki1 (AUTHOR), Asaoka, Masato1 (AUTHOR), Kagyo, Junko1 (AUTHOR), Katayama, Makoto2 (AUTHOR), Terai, Hideki3,4 (AUTHOR), Nakamura, Kohei5 (AUTHOR), Nishihara, Hiroshi5 (AUTHOR), Fukunaga, Koichi3 (AUTHOR)
Source: Thoracic Cancer. Oct2025, Vol. 16 Issue 20, p1-2. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17597706
DOI:10.1111/1759-7714.70176